Trimetazidine improves exercise performance in patients with peripheral arterial disease

Pharmacological Research

Volumn 63, Issue 4, 2011, Pages 278-283

  Vitale, Cristiana ^a   Marazzi, Giuseppe ^a   Pelliccia, Francesco ^b   Volterrani, Maurizio ^a   Cerquetani, Elena ^a   Spoletini, Ilaria ^a   Mercuro, Giuseppe ^c   Bonassi, Stefano ^a   Dall'Armi, Valentina ^a   Fini, Massimo ^a   Rosano, Giuseppe M C ^a,d  

^a IRCCS SAN RAFFAELE PISANA   (Italy)

^b SAN FILIPPO NERI HOSPITAL   (Italy)

^c UNIVERSITY OF CAGLIARI   (Italy)

^d Istituto San Raffaele Sulmona   (Italy)

Author keywords

Exercise performance; Peripheral arterial disease; Trimetazidine

Indexed keywords

TRIMETAZIDINE;

AEROBIC EXERCISE; AGED; ANKLE BRACHIAL INDEX; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; EXERCISE; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; INTERMITTENT CLAUDICATION; ISOTONIC EXERCISE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREADMILL EXERCISE; TREATMENT DURATION; WALKING SPEED;

AGED; ANKLE BRACHIAL INDEX; EXERCISE; EXERCISE TEST; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; TRIMETAZIDINE; VASODILATOR AGENTS;

EID: 79951809025     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2011.01.003     Document Type: Article

References (38)

1. A.T. Hirsch, Z.J. Haskal, N.R. Hertzer, C.W. Bakal, M.A. Creager, and J.L. Halperin ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation Circulation 113 2006 e463 e654
2. M.J. Salameh, and E.V. Ratchford Update on peripheral arterial disease and claudication rehabilitation Phys Med Rehabil Clin N Am 20 2009 627 656
3. J.P. van Kuijk, W.J. Flu, G.M. Welten, S.E. Hoeks, M. Chonchol, and R. Vidakovic Long-term prognosis of patients with peripheral arterial disease with or without polyvascular atherosclerotic disease Eur Heart J 31 2010 992 999
4. T.A. Bauer, J.G. Regensteiner, E.P. Brass, and W.R. Hiatt Oxygen uptake kinetics during exercise are slowed in patients with peripheral arterial disease J Appl Physiol 87 1999 809 816 (Pubitemid 29375020)
5. M.M. McDermott, F. Hoff, L. Ferrucci, W.H. Pearce, J.M. Guralnik, and L. Tian Lower extremity ischemia, calf skeletal muscle characteristics, and functional impairment in peripheral arterial disease J Am Geriatr Soc 55 2007 400 406 (Pubitemid 46328126)
6. A. Szuba, R.K. Oka, R. Harada, and J.P. Cooke Limb hemodynamics are not predictive of functional capacity in patients with PAD Vasc Med 11 2006 155 163 (Pubitemid 46099259)
7. F. Lundgren, A.G. Dahllof, T. Schersten, and A.C. Bylund-Fellenius Muscle enzyme adaptation in patients with peripheral arterial insufficiency: spontaneous adaptation, effect of different treatments and consequences on walking performance Clin Sci (Lond) 77 1989 485 493 (Pubitemid 19257714)
8. J.G. Regensteiner, E.E. Wolfel, E.P. Brass, M.R. Carry, S.P. Ringel, and M.E. Hargarten Chronic changes in skeletal muscle histology and function in peripheral arterial disease Circulation 87 1993 413 421 (Pubitemid 23040910)
9. J.O. Holloszy, and E.F. Coyle Adaptations of skeletal muscle to endurance exercise and their metabolic consequences J Appl Physiol 56 1984 831 838 (Pubitemid 14142837)
10. Q. Liu, J.C. Docherty, J.C. Rendell, A.S. Clanachan, and G.D. Lopaschuk High levels of fatty acids delay the recovery of intracellular pH and cardiac efficiency in post-ischemic hearts by inhibiting glucose oxidation J Am Coll Cardiol 39 2002 718 725 (Pubitemid 34158171)
11. A.C. Chagas, P.M. Dourado, and F. Galvao Tde Modulation of cardiac metabolism during myocardial ischemia Curr Pharm Des 14 2008 2563 2571
12. G.D. Lopaschuk, R. Barr, P.D. Thomas, and J.R. Dyck Beneficial effects of trimetazidine in ex vivo working ischemic hearts are due to a stimulation of glucose oxidation secondary to inhibition of long-chain 3-ketoacyl coenzyme a thiolase Circ Res 93 2003 e33 e37
13. H. Ashrafian, J.D. Horowitz, and M.P. Frenneaux Perhexiline Cardiovasc Drug Rev 25 2007 76 97 (Pubitemid 46625291)
14. T.A. Platz, J.S. Wilson, J.A. Kline, G. Rushing, J.L. Parker, and E.M. Moore The beneficial effects of dichloroacetate in acute limb ischemia Mil Med 172 2007 628 633 (Pubitemid 46911322)
15. A.G. Bertoni, M.C. Whitt-Glover, H. Chung, K.Y. Le, R.G. Barr, and M. Mahesh The association between physical activity and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis Am J Epidemiol 169 2009 444 454
16. S.A. Carter Response of ankle systolic pressure to leg exercise in mild or questionable arterial disease N Engl J Med 287 1972 578 582
17. L. Watson, B. Ellis, and G.C. Leng Exercise for intermittent claudication Cochrane Database Syst Rev 2008 CD000990
18. I.I. Pipinos, A.R. Judge, J.T. Selsby, Z. Zhu, S.A. Swanson, and A.A. Nella The myopathy of peripheral arterial occlusive disease. Part 1. Functional and histomorphological changes and evidence for mitochondrial dysfunction Vasc Endovasc Surg 41 2007 481 489 (Pubitemid 350264699)
19. I.I. Pipinos, A.R. Judge, J.T. Selsby, Z. Zhu, S.A. Swanson, and A.A. Nella The myopathy of peripheral arterial occlusive disease. Part 2. Oxidative stress, neuropathy, and shift in muscle fiber type Vasc Endovasc Surg 42 2008 101 112 (Pubitemid 351559569)
20. A. Marbini, F. Gemignani, U. Scoditti, P. Rustichelli, M.M. Bragaglia, and E. Govoni Abnormal muscle mitochondria in ischemic claudication Acta Neurol Belg 86 1986 304 310
21. J. Manchester, X. Kong, J. Nerbonne, O.H. Lowry, and J.C. Lawrence Jr. Glucose transport and phosphorylation in single cardiac myocytes: rate-limiting steps in glucose metabolism Am J Physiol 266 1994 E326 E333
22. J.D. Anderson, F.H. Epstein, C.H. Meyer, K.D. Hagspiel, H. Wang, and S.S. Berr Multifactorial determinants of functional capacity in peripheral arterial disease: uncoupling of calf muscle perfusion and metabolism J Am Coll Cardiol 54 2009 628 635
23. T.A. Bauer, E.P. Brass, and W.R. Hiatt Impaired muscle oxygen use at onset of exercise in peripheral arterial disease J Vasc Surg 40 2004 488 493 (Pubitemid 39165024)
24. G.J. Kemp, N. Roberts, W.E. Bimson, A. Bakran, P.L. Harris, and G.L. Gilling-Smith Mitochondrial function and oxygen supply in normal and in chronically ischemic muscle: a combined 31P magnetic resonance spectroscopy and near infrared spectroscopy study in vivo J Vasc Surg 34 2001 1103 1110 (Pubitemid 33660674)
25. W. Rouslin Mitochondrial complexes I, II, III IV, and V in myocardial ischemia and autolysis Am J Physiol 244 1983 H743 H748
26. C. Vitale, M. Wajngaten, B. Sposato, O. Gebara, P. Rossini, and M. Fini Trimetazidine improves left ventricular function and quality of life in elderly patients with coronary artery disease Eur Heart J 25 2004 1814 1821 (Pubitemid 39330232)
27. R. Belardinelli, F. Lacalaprice, E. Faccenda, and L. Volpe Clinical benefits of a metabolic approach in the cardiac rehabilitation of patients with coronary artery disease Am J Cardiol 98 2006 25J 33J
28. G.M. Rosano, C. Vitale, and G. Fragasso Metabolic therapy for patients with diabetes mellitus and coronary artery disease Am J Cardiol 98 2006 14J 18J
29. G. Fragasso, P.M. Piatti Md, L. Monti, A. Palloshi, E. Setola, and P. Puccetti Short- and long-term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathy Am Heart J 146 2003 E18
30. H. Tuunanen, E. Engblom, A. Naum, K. Nagren, M. Scheinin, and B. Hesse Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy Circulation 118 2008 1250 1258
31. W.C. Stanley, F.A. Recchia, and G.D. Lopaschuk Myocardial substrate metabolism in the normal and failing heart Physiol Rev 85 2005 1093 1129 (Pubitemid 40894649)
32. L. Lee, J. Horowitz, and M. Frenneaux Metabolic manipulation in ischaemic heart disease, a novel approach to treatment Eur Heart J 25 2004 634 641 (Pubitemid 38579491)
33. P.F. Kantor, A. Lucien, R. Kozak, and G.D. Lopaschuk The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase Circ Res 86 2000 580 588 (Pubitemid 30165050)
34. W.C. Stanley Changes in cardiac metabolism: a critical step from stable angina to ischaemic cardiomyopathy Eur Heart J Suppl 3 2001 O2 O7
35. K.H. Tan, L. De Cossart, and P.R. Edwards Exercise training and peripheral vascular disease Br J Surg 87 2000 553 562 (Pubitemid 30261089)
36. L.J. Hands, P.J. Bore, G. Galloway, P.J. Morris, and G.K. Radda Muscle metabolism in patients with peripheral vascular disease investigated by 31P nuclear magnetic resonance spectroscopy Clin Sci (Lond) 71 1986 283 290 (Pubitemid 16058738)
37. W.R. Hiatt, J.G. Regensteiner, E.E. Wolfel, M.R. Carry, and E.P. Brass Effect of exercise training on skeletal muscle histology and metabolism in peripheral arterial disease J Appl Physiol 81 1996 780 788 (Pubitemid 26303231)
38. J. Shalhoub, M. Qureshi, and A. Davies Supervised exercise in intermittent claudication: a sedentary notion? Vascular 17 2009 66 73